Fulford (India) is currently trading at Rs. 1675.00, up by 15.00 points or 0.90% from its previous closing of Rs. 1660.00 on the BSE.
The scrip opened at Rs. 1660.00 and has touched a high and low of Rs. 1675.00 and Rs. 1660.00 respectively. So far 80 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1696.90 on 06-Aug-2014 and a 52 week low of Rs. 458.90 on 04-Sep-2013.
Last one week high and low of the scrip stood at Rs. 1696.90 and Rs. 1593.00 respectively. The current market cap of the company is Rs. 653.25 crore.
The promoters holding in the company stood at 74.95% while Institutions and Non-Institutions held 3.86% and 21.18% respectively.
Fulford India had utilized Rs 1.70 crore towards business expansion during the quarter ended June 30, 2014. The total amount utilized by the company towards business expansion till June 30, 2014 is Rs 5.80 crore. The remaining balance amount of Rs 34.45 crore continues to be invested in fixed deposits with banks pending utilization of the same.
The company had raised Rs 40.25 crore by issuing 700,000 equity shares of Rs 10 each at a premium of Rs 565 per share to its promoters Dashtag. The funds were raised to provide capital in order to permit the company to strengthen its position in the market and act on strategic business growth opportunities.
Fulford (India) is engaged in the business of manufacturing and marketing pharmaceutical consumer products, including cough tablets and herbal ointments, marketed under the trademarks - PEPS and ZAMBUK respectively. It offers medicines for the treatment of allergy and respiratory, arthritis and immunology, cancer therapies, cardiovascular, hepatitis, sun care, etc.
| Company Name | CMP |
|---|---|
| Redington | 227.50 |
| Adani Enterprises | 2228.00 |
| Amrapali Industries | 17.36 |
| Rashi Peripheral | 474.40 |
| PDS | 294.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: